MetaCap

Capstone Holding Corp. (CAPS)

NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.44-0.145 (-9.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CAPS stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$89.68
52-week range
1.42 – 28.50
Day range
1.42 – 1.54
Volume / Avg
21.11K / 153.70K
Beta
—

52-week range

$1.42$28.50

CAPS stock today

On Nov 20, CAPS ended the session at $1.44, shedding $0.145 (9.15%), versus the S&P 500's 3.70% decline. Trading was light, with 21.11K shares changing hands, about 14% of the average daily volume. Shares are 94.9% below their 52-week high of $28.50 and 1.8% above the 52-week low of $1.42, near the bottom of the past year's range.

Capstone has posted a net loss over the last twelve months (EPS of -$89.68), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Capstone

Company profile

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone. The company offers manufactured stone veneer under the Cultured Stone, Dutch Quality Stone, and Toro Stone brand names; natural stone under the Pangaea Stone brand name; panelized stone system under the Interloc brand name; mechanically attached stone veneer systems under the Beon Stone brand name; moisture management system under the D-Rain brand name; landscape and hardscape products under the Aura Natural Landscapes brand name; and modular masonry fireplaces under the Isokern brand name.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Matthew E. Lipman
Headquarters
Alsip, IL
Employees
93

Financial highlights

Full financials

In fiscal 2025, Capstone generated $46.9 million in revenue, up 4.5% from fiscal 2024. Capstone reported a net loss of $21.2 million, compared with a loss of $2.6 million a year earlier. Gross margin was 23.0% (up from 21.3%) and operating margin -23.4%.

Capstone annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2018FY 2017
Revenue$46.88M$44.88M$48.35M$-2.00M$0
Growth+4.47%-7.19%+2517.70%——
Net income$-21.23M$-2.56M$-3.82M$380.00K$1.75M
EPS (diluted)—$-34.87$-36.39$-0.01$-0.04

Analyst forecast

Forecast

Consensus (1 analysts)

none

Avg. price target

$3.00+108.33%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 17, 2026
EPS actual vs est.
$-1.28 vs —

CAPS news

All CAPS news

Capstone peers

Health Care sector
CAPS peer companies
CompanyPrice% ChgMarket capCompare
CMNDClearmind Medicine Inc.2.63-17.68%$1.33Mvs CAPS
ELABPMGC Holdings Inc.1.14-10.24%$1.33Mvs CAPS
ARTLArtelo Biosciences Inc.1.39-4.14%$1.30Mvs CAPS
APVOAptevo Therapeutics Inc.0.4041-2.37%$1.40Mvs CAPS
JUNSJupiter Neurosciences Inc.1.24-18.75%$1.63Mvs CAPS
PRFXPRF Technologies Ltd.0.4758-23.68%$1.66Mvs CAPS
GOVXGeoVax Labs Inc.1.81-5.24%$985.46Kvs CAPS
BDRXBiodexa Pharmaceuticals plc American Depositary Shs1.88-3.85%$982.95Kvs CAPS

Indexes, lists and sector

Capstone stock FAQ

What is Capstone's stock price today?

CAPS last traded at $1.44 as of Nov 20, 4:00 PM EST, down 9.15% on the day. Prices are delayed at least 15 minutes.

Does Capstone pay a dividend?

No. Capstone does not currently pay a regular cash dividend.

Who is Capstone's CEO?

Mr. Matthew E. Lipman is the chief executive officer of Capstone Holding Corp., which has about 93 employees.

Has CAPS ever split its stock?

Yes. The most recent CAPS stock split was a 1-for-30 split on Oct 19, 2026.

What is the CAPS 52-week high?

The 52-week high for CAPS is $28.50 and the 52-week low is $1.42. The stock is currently 94.9% below its high.

Compare CAPS